Soliton, Inc. (SOLY) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Devices Branche. Der Hauptsitz des Unternehmens ist in Houston, TX, United States. Der aktuelle CEO ist Christopher C. Capelli.
SOLY hat IPO-Datum 2019-02-19, 13 Vollzeitbeschäftigte, gelistet an der NASDAQ Capital Marke.
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.
